Literature DB >> 30562687

Preparation, characterization and application of anti-human OX40 ligand (OX40L) monoclonal antibodies and establishment of a sandwich ELISA for autoimmune diseases detection.

Jingnan An1, Sisi Ding2, Xiaohan Hu3, Lili Sun2, Yanzheng Gu4, Yunyun Xu3, Yumin Hu2, Cuiping Liu5, Xueguang Zhang6.   

Abstract

OX40L (CD252, TNFSF4), a type II transmembrane protein which like other tumor necrosis factor ligands, involved in the costimulation and differentiation of T cells, functions as a positive signal in immune response. To investigate the biological function of soluble OX40L (sOX40L), three functional anti-OX40L monoclonal antibodies (mAbs) 3D2, 3F7 and 2H3 were obtained by hybridoma technology. Besides, specificity of the mAbs was further demonstrated by ELISA, Western blot and Immunofluorescence experiments. We also developed a novel enzyme-linked immunosorbent assay (ELISA) based on two anti-human OX40L antibodies 3D2 and 3F7 with different epitopes. Using the ELISA system, we found that sOX40L in the sera of healthy donors increases in an age-dependent manner and that enhanced sOX40L expression in some autoimmune diseases especially in rheumatoid arthritis (RA) patients, suggesting the potential diagnostic significance of sOX40L in the autoimmune diseases. Together, these data demonstrate that the existence of circulating sOX40L in human sera might play an important role in immunoregulation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Autoimmune disease; Costimulatory molecular; ELISA; OX40L

Mesh:

Substances:

Year:  2018        PMID: 30562687     DOI: 10.1016/j.intimp.2018.11.053

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  2 in total

1.  Establishment of a novel double-monoclonal antibody sandwich enzyme-linked immunosorbent assay (ELISA): tool for human B7-H4 detection in autoimmune diseases.

Authors:  Sisi Ding; Hengxin Zhou; Yanzheng Gu; Yu Shen; Li Zhang; Huayang Zhao; Jian Wu; Xueguang Zhang; Xin Chang; Cuiping Liu
Journal:  Clin Exp Immunol       Date:  2021-06-06       Impact factor: 5.732

2.  Study of The Correlation between miR-106a, miR-125b, and miR-330 on Multiple Sclerosis Patients by Targeting TNFSF4 and SP1 in NF-кb/TNF-α Pathway: A Case-Control Study.

Authors:  Nasrin Hadi; Seyed Morteza Seifati; Behnaz Nateghi; Parisa Ravaghi; Farinaz Khosravian; Faezeh Namazi; Maryam Fotouhi Firouzabad; Vahid Shaygannejad; Mansoor Salehi
Journal:  Cell J       Date:  2022-07-27       Impact factor: 3.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.